Metformin has been in the news a lot lately! This common diabetes medication was evaluated in a randomized, double-blind clinical trial called COVID-OUT. As reported
The COVID-OUT clinical trial found that the common diabetes medication metformin was effective in reducing serious health outcomes of COVID-19 by more than half when
The Parsemus Foundation and Revolution Contraceptives LLC are pleased to announce that NEXT Life Sciences, Inc. has been selected to continue development of the Vasalgel
Increased use of mammography has led to increased diagnoses of ductal carcinoma in situ (DCIS), which refers to noninvasive cancer cells in the milk ducts
A healthy lifestyle contributes to healthy aging and avoiding common diseases like diabetes and Alzheimer’s, and that includes our dietary choices. Some foods contain nutrients
In its “Less is More” series of articles, the Journal of the American Medical Association documents the problems of overuse of medical care. “Overused” procedures
A medication called baricitinib (brand name Olumiant), which is commonly used to treat rheumatoid arthritis, reduces the risk of death by 13% in hospitalized COVID-19
The Male Contraceptive Initiative’s Youth Advisory Board recently selected four undergraduate students for awards to fund research in male contraception. The Parsemus Foundation is proud
Despite warnings from medical professionals, the social media buzz about ivermectin’s ability to cure COVID has continued. The result has been a tremendous increase in
The Male Contraceptive Initiative announced that the Youth Advisory Board Undergraduate Project Grant program is accepting applications until September 30, 2021. The grant aims to
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:
